WATSON PHARMACEUTCLS WPI (NYSE)

$ 29.90
17:40
Change: +0.38 (+1.29%)
Volume: 1,386,100

Avg. Volume: 1024870
P/E Ratio: 19
EPS (Annual): 1.43
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 103,660
Institutional Shareholders: 94.12%
Last: 29.90
Change: +0.38 (+1.29%)
Prev. Close: 29.52
Open: 28.06
Day's Range: 28.06 - 30.02
52wk Range: 23.90 - 33.58
Market Value: 2,973,440
Beta: .92
12-month EPS Change: -128.42%
Total Return Last 12 Months: -8.51%
Total Return Last 3 Years: +0.52%
Total Return Last 5 Years: -26.46%
5-Year Revenue Growth Rate: 104.11%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: -22.56%


Headlines on WPI

Sector Snap: Teva-Barr talk lifts generics makers

(NEW YORK)Shares of Barr Pharmaceuticals Inc. soared Thursday on reports of buyout talks between Barr and industry leader Teva Pharmaceutical Industries Ltd. The speculation also lifted shar...READ MORE
Jul 17, 2008 3:17PM
Keywords: BRL, TEVA, SHPGY, MYL, MRK, NVS, WPI, WAT

Watson Pharma launches generic nausea drug

(CORONA, Calif.)Branded and generic drug maker Watson Pharmaceutical Inc. said Monday it launched a generic version of Solvay SA's Marinol, which treats chemotherapy-induced nausea.READ MORE
Jun 30, 2008 12:02PM
Keywords: WPI

Barr shares rise on Bayer birth control pills deal

(NEW YORK)Shares of Barr Pharmaceuticals Inc. rose Tuesday after the generic drug company announced an agreement to sell two Bayer birth control pills years before the last patents expire on...READ MORE
Jun 24, 2008 12:24PM
Keywords: BRL, WPI, NVS

Biovail stock falls after analyst cuts rating

(NEW YORK)Shares of drug developer Biovail Corp. sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts w...READ MORE
Jun 20, 2008 3:08PM
Keywords: BVF, TEVA, WPI, PRX

Watson Pharmaceuticals spent $295,000 on lobbying

(WASHINGTON)Branded and generic drug maker Watson Pharmaceuticals Inc. spent more than $295,000 lobbying in the first quarter, according to a recent disclosure form.READ MORE
Jun 18, 2008 1:07PM
Keywords: WPI

Sector Snap: Generic Drug Developers

(NEW YORK)Generic drug developers will continue taking advantage of global demand for lower-priced drugs, with industry giant Teva Pharmaceutical Industries Ltd. poised to maintain its lead ...READ MORE
Jun 11, 2008 12:12PM
Keywords: TEVA, MYL, MRK, WPI, BRL

BioSante Pharma retains Deutsche Bank as adviser

(LINCOLNSHIRE, Ill.)BioSante Pharmaceuticals Inc. said Tuesday it hired Deutsche Bank Securities Inc. to advise the company on strategic alternatives. Biosante is developing LibiGel, a topical testost...READ MORE
Jun 10, 2008 10:55AM
Keywords: BPAX, JNJ, AIS, WPI
Blogs on WPI
Feb 19, 2008 11:15am
Nov 9, 2007 3:40pm
Sep 28, 2007 11:00am
May 24, 2007 11:22am
Apr 16, 2007 3:45pm
Feb 28, 2007 6:15pm
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

TEVA PHARM INDS -3.20 42.87
MYLAN INC -21.70 12.83
BARR PHARMA INC +5.80 63.43
WATSON PHARMACE -3.10 29.90
ALPHARMA INC +1.00 24.51